A detailed history of Boston Trust Walden Corp transactions in Boston Scientific Corp stock. As of the latest transaction made, Boston Trust Walden Corp holds 11,181 shares of BSX stock, worth $994,549. This represents 0.01% of its overall portfolio holdings.

Number of Shares
11,181
Previous 11,181 -0.0%
Holding current value
$994,549
Previous $861,000 8.71%
% of portfolio
0.01%
Previous 0.01%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022

BUY
$35.24 - $47.1 $1,092 - $1,460
31 Added 0.28%
11,181 $417,000
Q4 2021

Jan 21, 2022

BUY
$38.07 - $44.87 $38,070 - $44,870
1,000 Added 9.85%
11,150 $474,000
Q1 2021

Apr 21, 2021

SELL
$35.27 - $39.67 $65,320 - $73,468
-1,852 Reduced 15.43%
10,150 $392,000
Q3 2020

Oct 14, 2020

SELL
$34.44 - $42.23 $5,062 - $6,207
-147 Reduced 1.21%
12,002 $459,000
Q1 2020

Apr 21, 2020

SELL
$25.83 - $45.71 $67,158 - $118,846
-2,600 Reduced 17.63%
12,149 $396,000
Q4 2019

Jan 10, 2020

SELL
$37.87 - $45.37 $13,368 - $16,015
-353 Reduced 2.34%
14,749 $667,000
Q3 2019

Oct 21, 2019

BUY
$40.31 - $43.45 $124,961 - $134,695
3,100 Added 25.83%
15,102 $615,000
Q3 2017

Oct 13, 2017

BUY
$26.26 - $29.17 $315,172 - $350,098
12,002
12,002 $350,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $127B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Boston Trust Walden Corp Portfolio

Follow Boston Trust Walden Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Trust Walden Corp, based on Form 13F filings with the SEC.

News

Stay updated on Boston Trust Walden Corp with notifications on news.